Tesamorelin & Ipamorelin Blend (8mg)

$90.00

Tesamorelin & Ipamorelin Blend (8mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines tesamorelin, a GHRH analogue, with ipamorelin, a synthetic ghrelin-receptor agonist.

  • Product: Tesamorelin & Ipamorelin Blend

  • Components: Tesamorelin and Ipamorelin

  • Listed quantity: 8 mg

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: tesamorelin-ipamorelin-blend-8mg Category:
Description

Tesamorelin & Ipamorelin Blend (8mg) for Laboratory Research

Tesamorelin & Ipamorelin Blend (8mg) is offered by Biotech Peptides for laboratories investigating growth-hormone secretagogue pathways and pituitary receptor signaling. The reference blend combines tesamorelin, a 44-amino-acid GHRH analogue, with ipamorelin, a five-amino-acid ghrelin-receptor agonist.

For laboratories looking to buy Tesamorelin & Ipamorelin Blend, this listing identifies an 8 mg quantity. Confirm the supplied material’s component identities, blend ratio, sequences, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Peptide Blend Product Information

Property Listing information
Product name Tesamorelin & Ipamorelin Blend
Components Tesamorelin and Ipamorelin
Listed quantity 8 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 8 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content, the ratio of the two components, or confirmation that a particular quantity-assay method has been performed.

Tesamorelin Reference Characteristics

The following characteristics describe the tesamorelin reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 44 amino acids
Peptide class GHRH analogue
N-terminal modification Trans-3-hexenoyl group
C-terminal group Amide
Molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S
Approximate molecular weight 5,136 g/mol
PubChem compound identifier 16137828

Tesamorelin is a synthetic analogue of human GHRH with a trans-3-hexenoyl group attached to Tyr1. The molecular formula, molecular weight, and compound identifier are documented in the PubChem Tesamorelin reference record.pubchem.ncbi.nlm.nih+1

Ipamorelin Reference Characteristics

The following characteristics describe the ipamorelin reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length Five amino acids
Amino-acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
One-letter sequence XHXFK
C-terminal group Amide
Molecular formula C₃₈H₄₉N₉O₅
Approximate molecular weight 711.9 g/mol
PubChem compound identifier 9831659

Ipamorelin contains the non-proteinogenic residue alpha-aminoisobutyric acid, or Aib, as well as D-2-naphthylalanine and D-phenylalanine. The sequence, molecular formula, molecular weight, and terminal-group description are documented

Receptor Pathways in Research

Tesamorelin is a GHRH analogue and has been studied in relation to GHRH receptor signaling. Ipamorelin is a ghrelin-receptor agonist and has been studied in relation to GHS-R1a signaling.

These are distinct receptor systems. A published review describes tesamorelin as a synthetic GHRH analogue that stimulates endogenous growth hormone secretion, while ipamorelin is described as a ghrelin mimetic with growth-hormone-releasing activity.

Read the review of growth hormone secretagogues for the receptor pathways and experimental context.

Synergy Is Context-Dependent

The term “synergy” describes a greater-than-additive response in a particular experimental system. It does not establish that a commercial blend will reproduce the same response in every assay, organism, or exposure condition.

Published research on GHRH and ghrelin-receptor agonists examines individual compounds and defined exposure conditions. It does not establish that a commercial tesamorelin and ipamorelin blend produces a predictable growth-hormone response in every biological system.

Research Limitations

Published research examines growth-hormone secretion, receptor signaling, and specific experimental models. It does not establish that a tesamorelin and ipamorelin blend improves body composition, reduces visceral fat, increases muscle mass, improves bone density, or treats any condition.

Published research also does not verify the identity, purity, quantity, component ratio, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting Tesamorelin & Ipamorelin Blend (8mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component identities and blend ratio.

  • Complete sequences and stereochemistry for both components.

  • Counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, ratios, or molecular values.

For inquiries, provide “Tesamorelin & Ipamorelin Blend (8mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Tesamorelin & Ipamorelin Blend (8mg)

What is tesamorelin?

Tesamorelin is a 44-amino-acid synthetic GHRH analogue with a trans-3-hexenoyl group attached to Tyr1.pubchem.ncbi.nlm.nih+1

What is ipamorelin?

Ipamorelin is a five-amino-acid synthetic peptide, Aib-His-D-2-Nal-D-Phe-Lys-NH₂, that acts as a ghrelin-receptor agonist.

Does a blend automatically produce synergistic effects?

No. Synergy is an experimental observation dependent on the specific materials, conditions, and biological system studied.

What does the 8mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Tesamorelin & Ipamorelin Blend (8mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery